Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Boston Scientific Corporation (BSX) had Revenue of $16.75B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$16.75B
Net Income	$1.85B
Cost of Goods Sold	$5.26B
Gross Profit	$11.49B
Operating Expenses	$14.14B
Operating Income	$2.60B
Non-Operating Income/Expense	$-321.00M
Pre-Tax Income	$2.28B
Normalized Pre-Tax Income	$2.28B
Income after Taxes	$1.85B
Income from Continuous Operations	$1.85B
Consolidated Net Income/Loss	$1.85B
Normalized Income after Taxes	$1.85B
EBIT	$2.60B
EBITDA	$4.26B
Weighted-Average Shares Outstanding (Basic)	1.47B
Weighted-Average Shares Outstanding (Diluted)	1.49B
Earnings per Share (EPS) (Basic)	$1.26
Earnings per Share (EPS) (Diluted)	$1.25
Balance Sheet Financials
Current Assets	$6.92B
Property, Plant, and Equipment	$3.29B
Long-Term Assets	$32.48B
Total Assets	$39.40B
Current Liabilities	$6.40B
Long-Term Debt	$8.97B
Long-Term Liabilities	$10.99B
Total Liabilities	$17.39B
Common Equity	$22.00B
Tangible Shareholders Equity	$-1.77B
Shareholders Equity	$22.00B
Common Shares Outstanding	1.47B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$3.44B
Cash Flow from Investing Activities	$-5.69B
Cash Flow from Financial Activities	$1.81B
Beginning Cash	$1.05B
End Cash	$606.00M
Increase/Decrease in Cash	$-450.00M
Stock-Based Compensation	$266.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.08
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.29
Debt to Equity Ratio	0.49
Gross Margin	68.61%
Operating Margin	15.55%
EBIT Margin	15.55%
EBITDA Margin	25.44%
Pre-Tax Profit Margin	13.63%
Profit Margin	11.06%
Free Cash Flow	$2.65B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.43
Inventory Turnover	1.87
Receiveable Turnover	6.55
Days Sales in Receivables	55.75
Return on Equity	8.39%
Return on Tangible Equity	-104.29%
Return on Assets	4.69%
Return on Investments	5.96%
Book Value Per Share	$14.92
Free Cash Flow per Share	$1.78
Operating Cash Flow per Share	$2.31

Data from Zacks Investment Research, Inc.